secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001193125-24-178568
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology appoints Jotin Marango as COO; grants 400K option tied to strategic transaction
--------------------------------------------------------------------------------

- Jotin Marango appointed COO effective July 15, 2024, in addition to his roles as CFO and Head of Corporate Development.
- Salary increased to $470,000 per year.
- Granted option to purchase 400,000 shares vesting upon consummation of a strategic transaction.
- Marango previously served as CFO since April 2022; prior roles at Aptose Biosciences and Roth Capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312524178568/0001193125-24-178568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312524178568/d646925d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-178568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer